this is unexpected, but very welcome
The incidence of heart attacks and strokes were reduced by 60% over a median follow-up period of 30
months following a single dose of rexlemestrocel-L in the population of 537 patients with New York
Heart Association (NYHA) class II or III chronic heart failure (5% vs 13%, p=0.002). Patients who
received rexlemestrocel-L had a 68% reduction in the rate of recurrent hospitalizations from non-fatal
heart attacks or strokes compared with controls, with a hospitalization rate of 1.90 per 100 patientyears of follow-up in the rexlemestrocel-L arm versus 5.95 per 100 patient-years of follow-up in the
control arm (p=0.0002).
V
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-9
-
- There are more pages in this discussion • 755 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $2.957M | 2.146M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 48935 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 216742 | 8 |
View Market Depth
| Last trade - 14.55pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |